Givairo Read player photo

Givairo Read

Feyenoord
NetherlandsRB20yrs

Latest Transfer News

Live updates on transfer rumours.

Contract Negotiations

Transfer Value

TransferFeed valuation based on market analysis.

€25.0M – €35.0M
Range
€30.0M
Most likely transfer value
€25.0MMost likely transfer value€35.0M
Market Analysis

Most recently, in May 2026, reports linked Manchester City with an expected transfer fee of approximately €30 million. In April 2026, it was reported that Feyenoord was demanding over €30 million, while Bayern Munich had set a firm limit of €30 million for the player. A range of €25-€30 million was also discussed in relation to Manchester City's interest. In January 2026, reports suggested Bayern could pay up to €35 million, with his Transfermarkt value listed at €25 million. In late 2025, various reports discussed a fee in the €25-€35 million range, with one outlet estimating his value at €20 million. Earlier, in March 2025, Feyenoord's valuation was consistently reported at €25-€30 million.

TransferFeed Verdict

Our valuation is driven by multiple, consistent reports from late 2025 through May 2026 detailing interest from top clubs, primarily Bayern Munich and Manchester City. The range is anchored by Feyenoord's reported demand of over €30 million and Bayern's firm negotiating limit of €30 million. The most likely value for Givairo Read is estimated at this €30 million figure, which is repeatedly cited as the expected fee and the central point of discussion.

Valuation updated: May 2026

Linked Clubs

Rumored destinations and interested clubs.

Powered by TransferFeed Intelligence™

Similar Players™ to Givairo Read

Michael Kayode is the closest match according to our proprietary analysis of transfer rumours and club connections.

Powered by TransferFeed Intelligence™

Contract Details

#26
Feyenoord logo
FEYENOORD
Contract until 30.6.2029.
Joined 1.7.2024.

Player Details

RBRight Back
Main Position

Right
Foot
175
Height

Follow Rumours

View transfer rumours on our TikTok, Instagram and X.